Search JIC Articles:
The Official Journal of the International Andreas Gruentzig Society
Saturday, September 6, 2008


text size: A A A
manuscripts: submit | review
Novel Intracoronary Steerable Support Catheter for Complex Coronary Intervention
Clinical Images:
Novel Intracoronary Steerable Support Catheter for Complex Coronary Intervention

- Srihari S. Naidu, MD and Shing-Chiu Wong, MD


       Case Description. A 69-year-old female with hypertension and hyperlipidemia presented
Figure 1
Angiogram showing rigid and calcified proximal curvature, with large, obstructive filling defect (calcified plaque) in the mid-vessel of the right coronary artery. Note the small residual lumen on the inner aspect of the lesion in this projection.
with a 2-month history of worsening exertional angina. Nuclear perfusion imaging indicated ischemia in the inferior and inferoposterior walls, with preserved left ventricular function. Coronary angiography was notable for severely calcified vessels and a right dominant circulation. The left anterior
Figure 2
The distal aspect of the Venture™ catheter is visible as the radiopaque segment in the proximal vessel. With the tip pointed 90º inferiorly, the wire was successfully directed to the residual lumen and advanced across the lesion.
descending and left circumflex arteries were free of critical stenosis, but the right coronary artery was tortuous in its proximal segment, with a 99% mid-vessel lesion that appeared as a calcified, obstructive filling defect on orthogonal imaging (Figure 1).
       Coronary intervention proceeded utilizing a 7 Fr Left Amplatz 1.0 guiding catheter. Due to proximal curvature, the wire was repeatedly deflected away from the residual lumen despite multiple attempts with different conventional wires and balloon catheter backup. This included attempts with BMW (Guidant Corp., Indianapolis, Indiana), Asahi Soft (Abbott Laboratories, Abbott Park, Illinois), and ChoICE™ PT2 (Boston Scientific, Natick, Massachusetts) wires. It was determined that poor support and an inability to precisely direct the wire toward the residual lumen were precluding success. A final attempt was thus made using the Venture™ steerable wire control catheter (Velocimed, Minneapolis, Minnesota). The catheter was positioned at the proximal bend and directed 90 degrees inferiorly into the mid-vessel. This provided directability and pushability to allow a soft, hydrophilic wire to pass alongside the stenosis with minimal resistance. Figure 2 shows the coronary guidewire across the stenosis, with the Venture catheter seated in the proximal vessel. The wire passed freely to the distal vasculature, and the Venture catheter was removed. After exchanging for a rotational atherectomy extra support wire, multiple passes were made with a 1.5 mm burr. Serial balloon dilatations and 3.5 mm drug-eluting stent placement to the proximal and mid-vessel produced the final result (Figure 3). The patient was discharged without events the following day.


       Discussion. This case demonstrates successful coronary intervention of a tortuous and calcified lesion requiring the Venture steerable wire control catheter. This is the first description of an intervention utilizing this novel support catheter. The Venture is a 6 Fr compatible, single-use, over-the-wire support
Figure 3
Final result after rotational atherectomy and placement of two overlapping drug-eluting stents in the proximal and mid-vessel.
catheter with an 8 mm radiopaque deflectable tip (Figure 4). The tip may be deflected to any degree between 0 and 90, resulting in enhanced directability and support. This may prove beneficial not only in rigid and
Figure 4
Specifications of the Venture™ steerable wire control catheter.
tortuous vessels, but chronic occlusions and high-grade stenoses, angulated takeoffs, ostia of bifurcations and stent-jailed side branches as well. The over-the-wire design and low profile allow for wire exchange and delivery of drugs to the peripheral coronary circulation, though its use is restricted to long wires.
       Interventional cardiologists are being asked to perform angioplasty in increasingly complex lesion subsets. Indeed, 54% of intervened lesions are ACC/AHA Type B2 or C.1 Despite improvements in operator technique and equipment, procedural failure still occurs in up to 10% and 20% of Type B2 and Type C lesions, respectively.2,3 Failure is most commonly due to chronic occlusion or high-grade stenosis, vessel tortuosity or moderate-to-severe calcification.2,4 The steerable wire control catheter allows directability and enhanced support, is compatible with all commercially available 0.014 inch long coronary guidewires, and can be used to improve procedural success in complex lesion and vessel morphology subsets.


1. Krone RJ, Shaw RE, Klein LW, et al. Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current “stent era” of coronary interventions (From the ACC-National Cardiovascular Data Registry). Am J Cardiol 2003;92:389–394.
2. Tan K, Sulke N, Taub N, Sowton E. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: Current experience. J Am Coll Cardiol 1995;25:855–865.
3. Krone RJ, Laskey WK, Johnson C, et al. A simplified lesion classification for predicting success and complications of coronary angioplasty. Am J Cardiol 2000;85:1179–1184.
4. Zaacks SM, Allen JE, Calvin JE, et al. Value of the American College of Cardiology/American Heart Association stenosis morphology classification for coronary interventions in the late 1990s. Am J Cardiol 1998;82:43–49.

The Journal of Invasive Cardiology - ISSN: 1042-3931 - Volume 18 - Issue 2 (February 2006) - February 2006 - Pages: 80 - 81



Novel Approaches to Managing Bradycardia during Coronary Rheolytic Thrombectomy

Special Supplement to the Journal of Invasive Cardiology


This special supplement was made possible through a grant from Possis Medical, Inc.
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE

On Demand Web Archive
Non-Accredited


This activity is supported by an educational grant from Terumo Medical Corporation.
Pharmacoinvasive Management of Acute Coronary Syndrome: Incorporating the 2007 ACC/AHA Guidelines

Complimentary Accredited CME Program

This activity is supported by an educational grant from Sanofi-Aventis.
Varicose Veins: Causes, Symptoms, Diagnosis and Treatment of Chronic Venous Insufficiency

A Complimentary Accredited ON-DEMAND Webcast

This activity is supported by an educational grant from Diomed, Inc.


Create a Successful Vena Cava Filter Practice

Accredited CD

This activity is supported by an educational grant from Cook Incorporated and has been designed for Interventional Cardiologists, Vascular Surgeons, Fellows and Interventional Cardiovascular Nurses and Technologists.

Achieving Optimal Outcomes in Carotid Stenting: Lessons Learned from Recent Clinical Trials
Complimentary Accredited ON DEMAND Webcast

Topics
1. EVA-3S & Space-Bumps in the road
2. CAPTURE 3500-Lesion morphology & Predictors for Stroke
3. CAPTURE II vs. EXACT 1500-Does open or Closed Cell Stent design really matter?

This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Neurologists, Interventional Nurses and Technologists with an interest in the diagnosis and treatment of peripheral artery disease.

Anticoagulation Techniques for Peripheral Vascular Interventions

Complimentary Accredited ON DEMAND Webcast

This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Podiatric Physicians, Endovascular Allied Professionals, Endocrinologists, Wound Care Specialists, Directors of the Wound Care Clinic, and Primary Care Physicians, Pharmacists, Nurses and Technologists.


March 2007 Supplement
On-Demand Webcast
Archived Webcast

About HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC, which also owns the North American Center for Continuing Medical Education (NACCME). NACCME provides a wide array of accredited CME offerings with industry thought leaders participating in roundtable meetings, webcasts, symposia, conferences, seminars, podcasts and satellite programs. Discover more about HMP’s products and services at www.hmpcommunications.com. ©2008 HMP Communications


© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd, Suite 100 | Malvern, PA 19355 | 800.237.7285